Insider Selling: Astera Labs (NASDAQ:ALAB) Director Sells 183,000 Shares

Key Points

  • Astera Labs director Manuel Alba sold 183,000 shares for approximately $51.3 million at an average price of $280.13, reducing his holdings by 41.9%. The transaction was made under a pre-arranged Rule 10b5-1 trading plan.
  • Astera Labs reported quarterly EPS of $0.80, beating the $0.69 consensus estimate, while revenue rose 104.5% year over year to $392.4 million. The company issued third-quarter EPS guidance of $1.16 to $1.21.
  • Analysts maintain a “Moderate Buy” consensus with an average price target of $348.33, although targets and ratings vary. Shares opened at $282.82, well below their 12-month high of $499.48, amid recent pressure despite continued demand for the company’s AI data-center connectivity products.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Manuel Alba sold 183,000 shares of the business's stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Manuel Alba also recently made the following trade(s):

  • On Wednesday, July 1st, Manuel Alba sold 136,974 shares of Astera Labs stock. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74.
  • On Wednesday, July 1st, Manuel Alba sold 37,535 shares of Astera Labs stock. The shares were sold at an average price of $447.39, for a total transaction of $16,792,783.65.
  • On Wednesday, July 1st, Manuel Alba sold 8,491 shares of Astera Labs stock. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58.

Astera Labs Trading Up 3.2%




Shares of ALAB opened at $282.82 on Friday. The stock has a market capitalization of $49.07 billion, a price-to-earnings ratio of 140.01 and a beta of 3.77. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a fifty day simple moving average of $332.37 and a 200 day simple moving average of $253.97.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company's revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for robust third-quarter growth and reinforcing the company’s AI data-center expansion story. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
  • Positive Sentiment: Astera’s role in supplying high-speed connectivity for large-scale AI data centers remains a key investment attraction, although NVIDIA retains a broader competitive advantage through its chips and software ecosystem. Better Artificial Intelligence Stock: Astera Labs vs. NVIDIA
  • Neutral Sentiment: The stock remains under pressure following its latest earnings report, declining 13.9% since results were released and 24% over the past month. The decline highlights elevated expectations and uncertainty about the next phase of growth. Why Is Astera Labs, Inc. (ALAB) Down 13.9% Since Last Earnings Report?
  • Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his position by 41.9%. Director Stefan Dyckerhoff also sold a combined 12,499 shares worth about $3.4 million. Both transactions were conducted under pre-arranged Rule 10b5-1 trading plans, which may lessen their signal as discretionary insider bearishness but could still weigh on sentiment and add selling supply. SEC Form 4 Filing

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently bought and sold shares of the business. Reflection Asset Management acquired a new stake in shares of Astera Labs in the fourth quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs in the 2nd quarter valued at $25,000. Archer Investment Corp bought a new stake in Astera Labs in the 2nd quarter valued at $30,000. Smartleaf Asset Management LLC lifted its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in Astera Labs during the 4th quarter valued at $33,000. Institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of analyst reports. TD Cowen decreased their price target on Astera Labs from $425.00 to $375.00 and set a "hold" rating for the company in a research note on Wednesday, August 5th. Barclays increased their price objective on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a report on Monday, July 20th. Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 target price for the company in a research note on Monday, August 17th. Morgan Stanley boosted their target price on shares of Astera Labs to $335.00 and gave the stock an "overweight" rating in a report on Monday, August 3rd. Finally, Susquehanna upped their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a "neutral" rating in a research report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $348.33.

Read Our Latest Report on Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Astera Labs?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Astera Labs and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles